In Brief: Martek Biosciences
This article was originally published in The Tan Sheet
Executive Summary
Martek Biosciences: Forms a licensing agreement with Sandoz Nutrition SA for the use of Martek's Formulaid oil in its infant formula, the firm announces Jan. 8. Martek also has agreements with Wyeth-Ayerst, Mead Johnson, Nutricia and the Israeli company Maabarot. Currently, Formulaid is used only in products marketed in Belgium and the Netherlands. Martek predicts a U.S. roll-out by the end of the year ("The Tan Sheet" Oct. 9, 1995, pp. 20-22)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning